Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia
Clinical trial NCT01357356 · COMPLETED
Trial details
- NCT number
- NCT01357356
- Sponsor
- Serenity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-10-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.